Weekly FDA Drug Pipeline Calendar (Nov 28 - Dec 2)
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Top Medical News of the Week
$Imago BioSciences (IMGO.US)$ traded higher after it was announced that it will be acquired by $Merck & Co (MRK.US)$ for $36 per share in cash. The deal totals an estimated $1.35 billion.
$Palisade Bio (PALI.US)$ announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return bowel function following surgery.
$Palisade Bio (PALI.US)$ announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return bowel function following surgery.
EVENTS TO WATCH
Clinical Trials on Alzheimer's Disease Conference - $Biogen (BIIB.US)$ $BioVie (BIVI.US)$ $ROCHE HOLDING AG (RHHBY.US)$ $Anavex Life Sciences (AVXL.US)$ Nov 29 - Dec 1
Nov Consumer Confidence 10 AM ET
Nov Consumer Confidence 10 AM ET
Wednesday, November 30
PDUFA PR $Scynexis (SCYX.US)$ BREXAFEMME (ibrexafungerp) - (CANDLE)
PDUFA PR $Y-mAbs Therapeutics (YMAB.US)$ Omburtamab
PDUFA PR $Y-mAbs Therapeutics (YMAB.US)$ Omburtamab
Source: CNBC, BioPharmCatalyst, Benzinga
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
We are the content provider of Moomoo Courses.
912Followers
8Following
1481Visitors
Follow
71156064 : I'll get excited when NWBO comes up for review.
BioPharm Insight US OP 71156064 : it's so volatile, trade safe.